We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Microchip Device for One Hour Antibiotic Resistance Testing

By LabMedica International staff writers
Posted on 08 Jun 2015
A novel electrochemical approach – designed to replace growth or fluorescent tests for drug resistance – can determine within one hour whether a culture of bacteria is susceptible to a particular antibiotic. More...


At present, the rapid determination of antibiotic susceptibility is hindered by the requirement that, in existing devices, bacteria must be pre-cultured for two to three days to reach detectable levels.

To break this bottleneck, investigators at the University of Toronto (Canada) designed a "lab-on-chip" device containing a series of minute flow-through wells patterned onto a glass chip. Each well has the capacity for only two nanoliters of growth medium and has a filter composed of microbeads at the bottom. The bacterial culture is passed through the well together with the antibiotic being tested, and the organisms are trapped by the filter at the bottom of the well. The bacteria accumulate in the wells, where they remain trapped with the antibiotic and the signal molecule resazurin.

Viable bacteria metabolize resazurin into resorufin, changing its electrochemical signature. If the bacteria are killed by the antibiotic, they stop metabolizing resazurin, and the electrochemical signature of the sample does not change. If they are antibiotic-resistant, they continue to metabolize resazurin into resorufin, altering its electrochemical signature. Electrodes built directly into the chip detect this change,

This electrochemical phenotyping approach was shown to be effective with clinically-relevant levels of bacteria and provided results comparable to culture-based analysis. Results, however, were delivered on a much faster timescale, with resistance profiles available after a single hour of incubation.

"Guessing can lead to resistance to these broad-spectrum antibiotics, and in the case of serious infections, to much worse outcomes for the patient," said first author Justin Besant, a graduate research student at the University of Toronto. "We wanted to determine whether bacteria are susceptible to a particular antibiotic, on a timescale of hours, not days. We have a lot of bacteria in a very small space, so our effective starting concentration is much higher, and as the bacteria multiply and convert the resazurin molecule, it is effectively stuck in this nanoliter droplet—it cannot diffuse away into the solution, so it can accumulate more rapidly to detectable levels."

"The electronics for our electrochemical readout can easily fit in a very small benchtop instrument, and this is something you could see in a doctor's office, for example," said Justin Besant. "The next step would be to create a device that would allow you to test many different antibiotics at many different concentrations, but we are not there yet."

The microchip device for assessing antibiotic resistance was described in the May 13, 2015, online edition of the journal Lab on a Chip.

Related Links:

University of Toronto 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.